ConjuChem

ConjuChem creates novel, next-generation medicines using unique, long-acting therapeutic peptides. Underlying all ConjuChem compounds are bioconjugation platforms called Drug Affinity Complex (DAC™) and Preformed Conjugate-Drug Affinity Complex (PC-DAC™). When applied to a given peptide, DAC™ and PC- DAC™ can create new drugs with similar therapeutic activities but with significantly longer durati...

Metabolic Disorders
Technology
1997
Founded
11-50
Employees
Metabolism Dysfunctions
Industry

Visual (Placeholder)

Profile Information

Name
ConjuChem
Industry
Metabolism Dysfunctions
Technology
Metabolic Disorders
Location
United States
Founded
1997
Employees
11-50
Category
Company

Contact Information

Email
JHodson@aaah.com
Phone
N/A
Address
N/A